Fujifilm buying Biogen’s Denmark manufacturing site for $890M

Biogen is selling its large-scale biologics manufacturing site in Hillerød, Denmark to Fujifilm for $890 million in cash.

Biogen Inc. (NASDAQ:BIIB) said it will enter into manufacturing services agreements with Fujifilm Holdings Corp. (Tokyo:4901), which will use the Hillerød site to produce commercial products for Biogen, such as Tysabri natalizumab, and other third-party products...